Once-daily vosoritide improved annualized growth velocity at 1 year for children with five different genetic subtypes of short stature, according to findings from a phase 2 basket trial.
New! Sign up for our free email newsletter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results